These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 899930)
1. Occurrence of hyperparathyroidism in children with X-linked hypophosphatemia under treatment with vitamin D and phsophate. Krohn HP; Offermann G; Brandis M; Brodehl J; Hanke K; Offner G Adv Exp Med Biol; 1977; 81():345-51. PubMed ID: 899930 [No Abstract] [Full Text] [Related]
3. Nature of defect responsible for familial vitamin D-resistant rickets (VDRR) based on radioimmunoassay for parathyroid hormone (PTH). Roof BS; Piel CF; Gordan GS Trans Assoc Am Physicians; 1972; 85():172-80. PubMed ID: 4349621 [No Abstract] [Full Text] [Related]
4. Use of phosphate and vitamin D to prevent dwarfism and rickets in X-linked hypophosphatemia. Glorieux FH; Scriver CR; Reade TM; Goldman H; Roseborough A N Engl J Med; 1972 Sep; 287(10):481-7. PubMed ID: 4340235 [No Abstract] [Full Text] [Related]
5. Familial forms of vitamin D-resistant rickets revisited. X-linked hypophosphatemia and autosomal recessive vitamin D dependency. Fraser D; Scriver CR Am J Clin Nutr; 1976 Nov; 29(11):1315-29. PubMed ID: 187056 [No Abstract] [Full Text] [Related]
6. Vitamin D-resistant rickets and parathyroid adenomas: renal transport of phosphate. Talwalkar YB; Musgrave JE; Buist NR; Campbell RA; Campbell JR Am J Dis Child; 1974 Nov; 128(5):704-8. PubMed ID: 4371252 [No Abstract] [Full Text] [Related]
7. Treatment of vitamin D resistant hypophosphataemic osteomalacia with 1alpha-hydroxy vitamin D3. Peacock M; Heyburn PJ; Aaron JE Calcif Tissue Res; 1977 May; 22 Suppl():55-62. PubMed ID: 912585 [No Abstract] [Full Text] [Related]
13. [Tubular and intestinal phosphate transport in vitamin D-resistant (hypophosphatemic) rickets (author's transl)]. Schabel F; Kurz R; Madreiter H; Reinken L; Zieglauer H Padiatr Padol; 1977; 12(2):152-7. PubMed ID: 193082 [TBL] [Abstract][Full Text] [Related]
14. Prolonged high-dose phosphate treatment: a risk factor for tertiary hyperparathyroidism in X-linked hypophosphatemic rickets. Mäkitie O; Kooh SW; Sochett E Clin Endocrinol (Oxf); 2003 Feb; 58(2):163-8. PubMed ID: 12580931 [TBL] [Abstract][Full Text] [Related]
15. Hypophosphatemia: mouse model for human familial hypophosphatemic (vitamin D-resistant) rickets. Eicher EM; Southard JL; Scriver CR; Glorieux FH Proc Natl Acad Sci U S A; 1976 Dec; 73(12):4667-71. PubMed ID: 188049 [TBL] [Abstract][Full Text] [Related]
16. [Attempt at studying calcium-phosphorus metabolism in vitamin-D-resistant rickets (phosphatic diabetes)]. Planeta-Malecka I; Kluska J; Konopińska H Wiad Lek; 1971 Dec; 24(23):2173-9. PubMed ID: 4334392 [No Abstract] [Full Text] [Related]
17. Exaggerated phosphaturic response to circulating parathyroid hormone in patients with familial X-linked hypophosphatemic rickets. Short E; Morris RC; Sebastian A; Spencer M J Clin Invest; 1976 Jul; 58(1):152-63. PubMed ID: 180058 [TBL] [Abstract][Full Text] [Related]
18. Inadequate bone response to phosphate and vitamin D in familial hypophosphatemic rickets (FHR). Glorieux FH; Bordier PJ; Marie P; Delvin EE; Travers R Adv Exp Med Biol; 1978; 103():227-32. PubMed ID: 213951 [No Abstract] [Full Text] [Related]
19. [Vitamin-D-resistant rickets: results of 12 months combined vitamin D and phosphate therapy]. Krohn HP; Brandis M; Brodehl J; Offner G Monatsschr Kinderheilkd (1902); 1976 May; 124(5):417-9. PubMed ID: 180401 [No Abstract] [Full Text] [Related]
20. Familial hypophosphatemic rickets: a delineation of its subdivisions and pathogenesis. Walton J Clin Pediatr (Phila); 1976 Nov; 15(11):1007-12. PubMed ID: 184998 [No Abstract] [Full Text] [Related] [Next] [New Search]